Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015819

SVP, Chief Accounting Officer sold 843 shares at $66.62 ($56,161)

  • SVP, Chief Accounting Officer acquired 3,710 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Sale : show line 1 in the form −843 $66.62 $56,161 13,229 D
2022-03-01 Grant or award : show line 2 in the form +3,710 17,046 D
Open-market sales · 843 sh · avg $66.62 · $56,161

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +7,400 7,400 D
Loading xslF345X03/doc4.xml…